शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

QUICKHEALNSEQuick Heal Technologies LimitedHighNeutral
Announced Tue, 6 May, 2025 · 23:02 IST

Quick Heal Technologies Limited has informed the Exchange regarding Outcome of Board Meeting held on May 06, 2025.

Revenue declinedNet loss reportedEBITDA margin compressionNegative operating cash flowResults View source PDFExplain this filing

QUICKHEAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+6.8%Reaction day
₹262.00
prior close
₹259.50
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+5.5% vs market

On the reaction day the stock moved 5.5 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.0
10m
-1.2
15m
-0.8
30m
-1.2
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
+6.8+1.3+5.5
Next day
+0.8+0.4+0.3
2d
-2.3+0.3-2.6
3d
+6.6+5.0+1.6
4d
+8.1+6.7+1.4
5d
+9.1+8.4+0.7
1w
+14.0+10.3+3.6
15d
+11.2+12.8-1.7
1m
+39.1+16.0+23.1
2m
+48.4+16.9+31.5
3m
+13.4+12.5+0.8
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Quick Heal's Board approved audited consolidated and standalone results for FY25 (year ended March 31, 2025). FY25 revenue fell 4.2% YoY to ₹279.5 Cr, dragged by a weak consumer segment (₹185.7 Cr, -9.2% YoY), while enterprise revenue grew modestly to ₹121.2 Cr (+1.5%). The company slipped into negative territory on profitability with EBITDA of ₹(6.6) Cr versus ₹17.6 Cr last year, and PAT collapsed 79% to ₹5.0 Cr. Q4 FY25 was particularly weak, with revenue down ~19% YoY at ₹65.1 Cr and a loss of ₹(3.3) Cr. Operating cash flow turned negative at ₹(22.3) Cr versus ₹18.2 Cr inflow a year ago, largely due to a ₹38.8 Cr jump in trade receivables. Statutory auditors (MSKA & Associates) issued an unmodified opinion, and Ruchi Bhave was appointed as Secretarial Auditor for five years.

Likely market impact

Weak set of numbers – top-line decline, negative EBITDA, sharply lower PAT and negative operating cash flow signal pressure on the business. The stock, already trading near its 52-week low (₹272.50 vs ₹825.90 high), may face further negativity in the near term, though the company highlighted a ₹24+ Cr order book and ₹12+ Cr deferred revenue as forward-looking positives.

By the numbersConsolidated · Q4 FY25 vs Q4 FY24
Q4 FY25Q4 FY24Change
Revenue₹65.14 Cr₹80.03 Cr−18.6%
Operating profit−₹12.17 Cr₹6.73 Cr−280.8%
Profit after tax−₹3.25 Cr₹14.04 Cr−123.1%
EBITDA margin-13.0%12.6%−25.6 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.